Germany
Japan
United Kingdom
China
Primary Antibodies
View as table Download
USD 494.00
In Stock
USD 494.00
2 Weeks
HES1 mouse monoclonal antibody, clone OTI1B9 (formerly 1B9), Biotinylated
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Biotin |
HES1 mouse monoclonal antibody, clone OTI2H4 (formerly 2H4), Biotinylated
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Biotin |
USD 494.00
2 Weeks
USD 494.00
2 Weeks
USD 494.00
2 Weeks
purified CD44 biotinylated mouse monoclonal detection antibody, validated for Luminex assays
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Biotin |
| Matched ELISA Pair | TA600541 |
USD 494.00
2 Weeks
purified CD44 biotinylated mouse monoclonal detection antibody, validated for Luminex assays
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Biotin |
| Matched ELISA Pair | TA600542 |
USD 494.00
2 Weeks
purified CD44 biotinylated mouse monoclonal detection antibody, validated for Luminex assays
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Biotin |
| Matched ELISA Pair | TA600543 |
USD 494.00
2 Weeks
purified CD44 biotinylated mouse monoclonal detection antibody, validated for Luminex assays
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Biotin |
| Matched ELISA Pair | TA600544 |
Active filters
Conjugates
- Biotin
Families
- Stem cell relevant signaling - DSL/Notch pathway
Filter by
Category
Target Symbol
Reactivities
Antibody Hosts
Isotypes
Clonalities
Knockout (KO) Validation
Assay Types
Assay Platforms
Pathways
- Pathways in cancer (51)
- Basal cell carcinoma (29)
- Hedgehog signaling pathway (29)
- Chronic myeloid leukemia (22)
- Notch signaling pathway (21)
- ECM-receptor interaction (20)
- Hematopoietic cell lineage (20)
- Jak-STAT signaling pathway (18)
- Acute myeloid leukemia (17)
- ErbB signaling pathway (13)
- Maturity onset diabetes of the young (11)
- Cell cycle (9)
- Huntington's disease (5)
- Bladder cancer (4)
- Colorectal cancer (4)
- Endometrial cancer (4)
- Focal adhesion (4)
- Glioma (4)
- Melanoma (4)
- Non-small cell lung cancer (4)
- Pancreatic cancer (4)
- Prostate cancer (4)
- Small cell lung cancer (4)
- Thyroid cancer (4)
- Viral myocarditis (4)
- Wnt signaling pathway (4)
- p53 signaling pathway (4)
- Dorso-ventral axis formation (3)
- Prion diseases (3)
- Cytokine-cytokine receptor interaction (1)